Novavax, Inc. (NASDAQ: NVAX) reported Q4 EPS of $0.03, $0.07 better than the analyst estimate of ($0.04). Revenue for the quarter came in at $5.85 million versus the consensus estimate of $6.87 million.

For earnings history and earnings-related data on Novavax, Inc. (NVAX) click here.

Earnings